What it sells
Live intelligence for biopharma teams.
Business model breakdown
Buyer: who owns the budget?
UnverifiedHeads of competitive intelligence, BD, medical affairs or research at biopharma, or partners at consultancies/funds (inferred).
Trigger: what makes them buy now?
Research files go stale between reviews as trials, regulatory/HTA decisions and company news change; teams need to know what changed before the next decision.
Workflow: what inputs become what output?
Research Agent, Smart Tables and Document Grids investigate and compare trials/drugs; monitors detect changes and apply source-linked edits to Word, Excel and PowerPoint files; also exposed via MCP, API and webhooks.
Economics: what it saves and how it charges
Annual team licensing with pooled AI credits, plus data/API/MCP/product-integration add-ons, scoped per customer.
Distribution: how it reaches customers
Demo-led sales (Book a demo / Request a quote) with MCP connector and Claude plugin for assistants.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Summer 2023 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.